Human Papillomavirus 16 Lineage D is Associated with High Risk of Cervical Cancer in the Brazilian Northeast Region

被引:0
|
作者
Martins, Luis Felipe Leite [1 ]
Moreira, Miguel Angelo Martins [2 ]
Pinto, Rodrigo Alves [3 ]
Reis, Neilane Bertoni dos [4 ]
Felix, Shayany Pinto [2 ]
Vidal, Joao Paulo Castello Branco [5 ]
Torres, Leuridan Cavalcante [3 ]
Souza, Ariani Impieri [3 ,7 ]
de Almeida, Liz Maria [6 ]
机构
[1] Inst Nacl Canc, Canc Surveillance & Data Anal Div, Rio De Janeiro, RJ, Brazil
[2] Inst Nacl Canc, Tumor Genet & Virol Program, Rio De Janeiro, RJ, Brazil
[3] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil
[4] Inst Nacl Canc, Div Populat Res, Rio De Janeiro, RJ, Brazil
[5] Univ Fed Maranhao, Sao Luis, MA, Brazil
[6] Inst Nacl Canc, Coordinat Prevent & Surveillance, Rio De Janeiro, RJ, Brazil
[7] Rua Coelhos, 300, BR-50070902 Recife, PE, Brazil
来源
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2023年 / 45卷 / 08期
关键词
HPV16; lineage A; lineage D; CIN2/CIN3; cervical cancer; VARIANTS; TYPE-16; LESIONS; HPV16; WOMEN; CARCINOMA; DIVERSITY; E6;
D O I
10.1055/s-0043-1772180
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective Similar to Human Papillomavirus (HPV) genotypes, different lineages of a genotype also have different carcinogenic capabilities. Studies have shown that specific genotype lineages of oncogenic HPV are associated with variable risks for the development of cervical intraepithelial neoplasia (CIN2/CIN3) and cervical cancer. The present study aimed to analyze the genetic diversity of the HPV16 genotype in women with CIN2/CIN3 and cervical cancer, from the northeast region of Brazil.Methods A cross-sectional multicenter study was conducted in the northeast region of Brazil, from 2014 to 2016. This study included 196 cases of HPV16 variants (59 and 137 cases of CIN2/CIN3 and cervical cancer, respectively). The difference of proportion test was used to compare patients with CIN2/CIN3 and cervical cancer, based on the prevalent HPV16 lineage ( p < 0.05).Results According to the histopathological diagnosis, the percentage of lineage frequencies revealed a marginal difference in the prevalence of lineage A in CIN2/CIN3, compared with that in cervical cancer ( p = 0.053). For lineage D, the proportion was higher in cancer cases (32.8%), than in CIN2/CIN3 cases (16.9%), with p = 0.023.Conclusion HPV16 lineage A was the most frequent lineage in both CIN2/CIN3 and cervical cancer samples, while lineage D was predominant in cervical cancer, suggesting a possible association between HPV16 lineage D and cervical cancer.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 50 条
  • [11] Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population
    Hang, Dong
    Yin, Yin
    Han, Jing
    Jiang, Jie
    Ma, Hongxqia
    Xie, Shuanghua
    Feng, Xiaoshuang
    Zhang, Kai
    Hu, Zhibin
    Shen, Hongbing
    Clifford, Gary M.
    Dai, Min
    Li, Ni
    VIROLOGY, 2016, 488 : 156 - 161
  • [12] Association of human papillomavirus type 16 long control region mutation and cervical cancer
    Chamsai Pientong
    Parichat Wongwarissara
    Tipaya Ekalaksananan
    Piyawut Swangphon
    Pilaiwan Kleebkaow
    Bunkerd Kongyingyoes
    Sumalee Siriaunkgul
    Kobkul Tungsinmunkong
    Cheepsumon Suthipintawong
    Virology Journal, 10
  • [13] Lineage distribution and E2 sequence variation of high-risk human papillomavirus types isolated from patients with cervical cancer in Sichuan province, China
    Wu, Haijing
    Wu, Enqi
    Ma, Lin
    Zhang, Guonan
    Shi, Yu
    Huang, Jianming
    Zha, Xiao
    ARCHIVES OF VIROLOGY, 2015, 160 (11) : 2845 - 2855
  • [14] Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women
    Clifford, Gary M.
    Tenet, Vanessa
    Georges, Damien
    Alemany, Laia
    Angel Pavon, Miquel
    Chen, Zigui
    Yeager, Meredith
    Cullen, Michael
    Boland, Joseph F.
    Bass, Sara
    Steinberg, Mia
    Raine-Bennett, Tina
    Lorey, Thomas
    Wentzensen, Nicolas
    Walker, Joan
    Zuna, Rosemary
    Schiffman, Mark
    Mirabello, Lisa
    PAPILLOMAVIRUS RESEARCH, 2019, 7 : 67 - 74
  • [15] Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia
    Bokal, Eda Vrtacnik
    Kocjan, Bostjan J.
    Poljak, Mario
    Bogovac, Zeljka
    Jancar, Nina
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (06) : 1204 - 1213
  • [16] Intratypic variants of human papillomavirus type 16 and risk of cervical Neoplasia in Taiwan
    Chang, Ya-Ju
    Chen, Hui-Chi
    Pan, Mei-Hung
    Lee, Bor-Heng
    You, San-Lin
    Lin, Ching-Yu
    Chou, Yi-Chun
    Hsieh, Chang-Yao
    Cheng, Yu-Juen
    Liaw, Kai-Li
    Hsing, Ann W.
    Schiffman, Mark
    Chen, Chien-Jen
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (09) : 1567 - 1576
  • [17] Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand
    Chopjitt, Peechanika
    Ekalaksananan, Tipaya
    Pientong, Chamsai
    Kongyingyoes, Bunkerd
    Kleebkaow, Pilaiwan
    Charoensri, Nicha
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (02) : 212 - 219
  • [18] Prevalence and Genotyping of High Risk Human Papillomavirus in Cervical Cancer Samples from Punjab, Pakistan
    Siddiqa, Abida
    Zainab, Maidah
    Qadri, Ishtiaq
    Bhatti, Muhammad Faraz
    Parish, Joanna L.
    VIRUSES-BASEL, 2014, 6 (07): : 2762 - 2777
  • [19] Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
    Ji, Sha
    Ji, Nannan
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [20] Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection
    Zeber-Lubecka, Natalia
    Kulecka, Maria
    Dabrowska, Michalina
    Baginska-Drabiuk, Katarzyna
    Glowienka-Stodolak, Maria
    Nowakowski, Andrzej
    Slabuszewska-Jozwiak, Aneta
    Bednorz, Bozena
    Jedrzejewska, Ilona
    Piasecka, Magdalena
    Pawelec, Jolanta
    Wojciechowska-Lampka, Elzbieta
    Ostrowski, Jerzy
    PLOS ONE, 2024, 19 (04):